Synthesis and structure-activity relationships of small-molecular di-basic esters, amides and carbamates as flaviviral protease inhibitors

被引:4
|
作者
Sundermann, Tom R. [1 ,2 ]
Benzin, Clarissa, V [1 ]
Drazic, Tonko [1 ]
Klein, Christian D. [1 ]
机构
[1] Heidelberg Univ, Med Chem, IPMB, Neuenheimer Feld 364, D-69120 Heidelberg, Germany
[2] Univ Hosp Heidelberg, Inst Forens & Traff Med, Vossstr 2, D-69115 Heidelberg, Germany
关键词
Flavivirus; Dengue; Protease; Covalent-reversible inhibition; Carbamate; Ester; VIRUS PROTEASE; DENGUE; DISCOVERY;
D O I
10.1016/j.ejmech.2019.05.025
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Inhibitors of the flaviviral serine proteases, which are crucial for the replication of dengue and West-Nile virus, have attracted much attention over the last years. A dibasic 4-guanidinobenzoate was previously reported as inhibitor of the dengue protease with potency in the low-micromolar range. In the present study, this lead structure was modified with the intent to explore structure-activity relationships and obtain compounds with increased drug-likeness. Substitutions of the guanidine moieties, the aromatic rings, and the ester with other functionalities were evaluated. All changes were accompanied by a loss of inhibition, indicating that the 4-guanidinobenzoate scaffold is an essential element of this compound class. Further experiments indicate that the target recognition of the compounds involves the reversible formation of a covalent adduct. (C) 2019 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:187 / 194
页数:8
相关论文
共 50 条
  • [41] Structure-activity relationship of small-sized HIV protease inhibitors containing allophenylnorstatine
    Mimoto, T
    Kato, R
    Takaku, H
    Nojima, S
    Terashima, K
    Misawa, S
    Fukazawa, T
    Ueno, T
    Sato, H
    Shintani, M
    Kiso, Y
    Hayashi, H
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (10) : 1789 - 1802
  • [42] Understanding Structure-Activity Relationships for Trypanosomal Cysteine Protease Inhibitors by Simulations and Free Energy Calculations
    Santos, Lucianna H.
    Waldner, Birgit J.
    Fuchs, Julian E.
    Pereira, Glaecia A. N.
    Liedl, Klaus R.
    Caffarena, Ernesto R.
    Ferreira, Rafaela S.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2019, 59 (01) : 137 - 148
  • [43] Synthesis, Structure-Activity Relationships and Biological Activity of New Isatin Derivatives as Tyrosinase Inhibitors
    Gencer, Nahit
    Sonmez, Fatih
    Demir, Dudu
    Arslan, Oktay
    Kucukislamoglu, Mustafa
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (12) : 1450 - 1462
  • [44] Structure-activity relationships for a class of selective inhibitors of the major cysteine protease from Trypanosoma cruzi
    Guido, Rafael V. C.
    Trossini, Gustavo H. G.
    Castilho, Marcelo S.
    Oliva, Glaucius
    Ferreira, Elizabeth I.
    Andricopulo, Adriano D.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2008, 23 (06) : 964 - 973
  • [45] Molecular modeling and structure-activity relationships for a series of benzimidazole derivatives as cruzain inhibitors
    Pauli, Ivani
    Ferreira, Leonardo G.
    de Souza, Mariana L.
    Oliva, Glaucius
    Ferreira, Rafaela S.
    Dessoy, Marco A.
    Slafer, Brian W.
    Dias, Luiz C.
    Andricopulo, Adriano D.
    FUTURE MEDICINAL CHEMISTRY, 2017, 9 (07) : 641 - 657
  • [46] Structure-activity relationships for the selectivity of hepatitis C virus NS3 protease inhibitors
    Poliakov, A
    Johansson, A
    Åkerblom, E
    Oscarsson, K
    Samuelsson, B
    Hallberg, A
    Danielson, UH
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2004, 1672 (01): : 51 - 59
  • [47] Cycloalkylpyranones and cycloalkyldihydropyrones as HIV protease inhibitors: Exploring the impact of ring size on structure-activity relationships
    Romines, KR
    Morris, JK
    Howe, WJ
    Tomich, PK
    Horng, MM
    Chong, KT
    Hinshaw, RR
    Anderson, DJ
    Strohbach, JW
    Turner, SR
    Mizsak, SA
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (20) : 4125 - 4130
  • [48] Design and structure-activity relationships of novel inhibitors of human rhinovirus 3C protease
    Kawatkar, S. P.
    Gagnon, M.
    Hoesch, V.
    Tiong-Yip, C.
    Johnson, K.
    Ek, M.
    Nilsson, E.
    Lister, T.
    Olsson, L.
    Patel, J.
    Yu, Q.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (14) : 3248 - 3252
  • [49] Synthesis and structure-activity relationships of dehydroaltenusin derivatives as selective DNA polymerase α inhibitors
    Kuramochi, Kouji
    Fukudome, Keishi
    Kuriyama, Isoko
    Takeuchi, Toshifumi
    Sato, Yoshihiro
    Kamisuki, Shinji
    Tsubaki, Kazunori
    Sugawara, Fumio
    Yoshida, Hiromi
    Mizushina, Yoshiyuki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (20) : 7227 - 7238
  • [50] Synthesis and structure-activity relationships for tetrahydroisoquinoline-based inhibitors of Mycobacterium tuberculosis
    Lu, Guo-Liang
    Tong, Amy S. T.
    Conole, Daniel
    Sutherland, Hamish S.
    Choi, Peter J.
    Franzblau, Scott G.
    Upton, Anna M.
    Lotlikar, Manisha U.
    Cooper, Christopher B.
    Denny, William A.
    Palmer, Brian D.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (22)